BCRX
NASDAQ · Biotechnology
Biocryst Pharmaceuticals Inc
$8.68
-0.02 (-0.23%)
Open$8.60
Previous Close$8.70
Day High$8.84
Day Low$8.49
52W High$11.22
52W Low$6.00
Volume—
Avg Volume5.11M
Market Cap2.22B
P/E Ratio—
EPS$-1.50
SectorBiotechnology
Analyst Ratings
Strong Buy
17 analysts
Price Target
+661.8% upside
Current
$8.68
$8.68
Target
$66.12
$66.12
$46.17
$66.12 avg
$78.89
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.03B | 695.83M | 328.14M |
| Net Income | 310.27M | 188.89M | -56,674,354 |
| Profit Margin | 30.2% | 28.7% | -17.3% |
| EBITDA | 382.20M | 245.62M | -75,730,538 |
| Free Cash Flow | — | — | -52,199,092 |
| Rev Growth | +47.8% | +47.8% | +7.1% |
| Debt/Equity | 2.09 | 2.09 | 0.16 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.99 | -0.08% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $406.46 | -0.92% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.37 | -1.51% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $799.26 | -0.58% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $246.45 | -2.07% | 40.0 | 32.33B |